Genetic Counseling 2.0: As genetic testing ramps up in the clinic and via consumer-oriented providers, companies leverage technology to scale genetic counseling services

2019 ◽  
Vol 6 (6) ◽  
pp. 20-23
2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e13009-e13009
Author(s):  
Jessica Ross ◽  
Donna Bell ◽  
Angela R. Yarbrough ◽  
Susan K. Peterson ◽  
Sukh Makhnoon ◽  
...  

e13009 Background: Numerous studies have explored genetic testing access and benefits in adult and pediatric cancer patients, however little is known about the use of these services in adolescents and young adult (AYA) cancer patients. Routine genetic counseling may be particularly important for AYAs who are survivors of childhood cancer, as 8.5% of children with cancer have an inherited pathogenic germline variant. Genetic testing also helps reduce cancer morbidity and mortality in adolescents, as well as helps to guide cancer prevention strategies in family members. This study describes an innovative approach to fostering AYA patients’ access to genetic counseling services. Methods: AYA patients (ages 15-29) with a new or prior cancer diagnosis were referred to MD Anderson Cancer Center’s AYA multi-disciplinary clinic. Prior to their clinic visits, a genetic counselor reviewed relevant medical and family history information for patients seen from 7/12/18 through 1/11/19. For those at risk for a hereditary cancer syndrome, a recommendation for a genetic counseling referral was given to the AYA medical provider based on established guidelines, professional consensus, and clinical judgement guided by thorough literature reviews. Results: In total, 254 AYA patients’ charts were reviewed and 70 (27.6%) patients had histories that warranted a genetic counseling referral. Of these 70 patients, 53 (75.7%) were not previously seen by genetics. Of the 53 patients newly recommended to be referred, 29 (54.7%) had referrals placed. Of the 24 patients not referred, 17 did not attend their AYA visit, 5 refused the referral, and 2 were not referred for undetermined reasons. Of those referred, 10 completed genetic counseling, 14 are scheduled for counseling, 3 did not attend their appointment, and 2 had counseling at another institution. This process led to a 41.3% absolute increase in referrals to genetic counseling for those at risk for hereditary cancer syndromes. Conclusions: The described clinic workflow identified gaps in genetic referrals and showed an innovative approach to fostering AYA access to genetic services. This approach may be useful for other institutions interested in increasing access to genetic services for AYAs.


1980 ◽  
Vol 56 (1) ◽  
pp. 1-5 ◽  
Author(s):  
E. Passarge ◽  
F. Vogel ◽  
K. Berg ◽  
N. P. Bochkov ◽  
A. Czeizel ◽  
...  

2014 ◽  
Vol 24 (1) ◽  
pp. 46-57 ◽  
Author(s):  
Stephanie Skinner ◽  
Colleen Guimond ◽  
Rachel Butler ◽  
Emily Dwosh ◽  
Anthony L. Traboulsee ◽  
...  

2014 ◽  
Vol 23 (6) ◽  
pp. 976-983 ◽  
Author(s):  
Allyson E. Somers ◽  
Stephanie M. Ware ◽  
Kathleen Collins ◽  
John L. Jefferies ◽  
Hua He ◽  
...  

2015 ◽  
Vol 35 (4) ◽  
pp. 370-375 ◽  
Author(s):  
Rajech Sharkia ◽  
Jalal Tarabeia ◽  
Abdelnaser Zalan ◽  
Esmael Atamany ◽  
Muhammad Athamna ◽  
...  

2018 ◽  
Vol 28 (5) ◽  
pp. 996-1002 ◽  
Author(s):  
Jubilee Brown ◽  
Aly Athens ◽  
David L. Tait ◽  
Erin K. Crane ◽  
Robert V. Higgins ◽  
...  

ObjectivesThe aim of this study was to demonstrate the utility of a comprehensive program involving management-based evidence, telemedicine, and patient navigation to provide genetic counseling services for patients with ovarian and breast cancer across a geographically large health care system.MethodsWe identified all patients with newly diagnosed ovarian and breast cancer in our health care system from January 2013 to December 2015 through the cancer registry. Referral characteristics and testing outcomes were recorded for each year and compared using the χ2 or Fisher exact test.ResultsBecause the implementation of this program, the number of new ovarian cancer cases remained constant (109–112 cases/year) but patients referred for genetic counseling increased annually from 37% to 43% to 96% (P < 0.05). The percentage of ovarian cancer patients who underwent genetic testing increased annually from 24% to 27% to 53% (P < 0.05). The number of new breast cancer patients was constant (1543–1638 cases/year). The percentage of patients with triple negative breast cancer referred for genetic counseling rose from 69% in 2013 to 91% in 2015; the percentage of patients who underwent testing increased annually from 59% to 86% (P < 0.05). Of women with breast cancer diagnosed at less than 45 years of age, 78% to 85% were referred for genetic counseling across this period; the percentage of patients who underwent testing increased annually from 66% to 82% (P < 0.05). Patient navigation was initiated and was available to all patients in the system during this period. Telemedicine consults were performed in 118 breast/ovarian patients (6%) during this period.ConclusionsA comprehensive program may improve access to effective genetic counseling services in patients with ovarian and breast cancer despite geographic barriers.


Sign in / Sign up

Export Citation Format

Share Document